• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New insights into the impact of impaired epigenetic machinery on liver cancer malignant phenotype.

作者信息

Marijuan Rebeca P, Marin Jose J G

机构信息

Experimental Hepatology and Drug Targeting (HEVEPHARM), Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain.

Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

出版信息

Transl Cancer Res. 2024 Sep 30;13(9):4514-4519. doi: 10.21037/tcr-24-751. Epub 2024 Sep 27.

DOI:10.21037/tcr-24-751
PMID:39430862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11483460/
Abstract
摘要

相似文献

1
New insights into the impact of impaired epigenetic machinery on liver cancer malignant phenotype.表观遗传机制受损对肝癌恶性表型影响的新见解。
Transl Cancer Res. 2024 Sep 30;13(9):4514-4519. doi: 10.21037/tcr-24-751. Epub 2024 Sep 27.
2
N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.N6-甲基腺苷阅读器YTHDF1通过增强NOTCH1表达促进肝癌的干性和治疗抗性。
Cancer Res. 2024 Mar 15;84(6):827-840. doi: 10.1158/0008-5472.CAN-23-1916.
3
Mettl3-m6A-YTHDF1 axis promotion of mitochondrial dysfunction in metabolic dysfunction-associated steatotic liver disease.Mettl3-m6A-YTHDF1 轴促进代谢相关脂肪性肝病中肝线粒体功能障碍。
Cell Signal. 2024 Sep;121:111303. doi: 10.1016/j.cellsig.2024.111303. Epub 2024 Jul 15.
4
Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.RNA N6-甲基腺苷相关基因在肝细胞癌患者中的表达谱及预后意义：来自独立数据集的证据
Cancer Manag Res. 2019 May 1;11:3921-3931. doi: 10.2147/CMAR.S191565. eCollection 2019.
5
WTAP Accelerates Exhaustion of CD8 T Cells and Progression of Hepatocellular Carcinoma by Promoting m6A Modification and Translation of PD1 mRNA.WTAP通过促进m6A修饰和PD1 mRNA的翻译加速CD8 T细胞耗竭和肝细胞癌进展。
Mediators Inflamm. 2025 Jun 18;2025:6217272. doi: 10.1155/mi/6217272. eCollection 2025.
6
m6A-YTHDF1 Mediated Regulation of GRIN2D in Bladder Cancer Progression and Aerobic Glycolysis.m6A-YTHDF1介导的GRIN2D在膀胱癌进展及有氧糖酵解中的调控作用
Biochem Genet. 2024 Jun 29. doi: 10.1007/s10528-024-10875-6.
7
YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.YTHDF1 通过以 m6A 依赖的方式促进 FZD5 mRNA 翻译来推动肝细胞癌进展。
Mol Ther Nucleic Acids. 2020 Oct 4;22:750-765. doi: 10.1016/j.omtn.2020.09.036. eCollection 2020 Dec 4.
8
Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma.长链非编码RNA与N6-甲基腺苷在肝细胞癌中的研究进展
Front Oncol. 2022 Jul 22;12:907399. doi: 10.3389/fonc.2022.907399. eCollection 2022.
9
High glucose facilitates hepatocellular carcinoma cell proliferation and invasion via WTAP-mediated HK2 mRNA stability.高糖通过WTAP介导的HK2 mRNA稳定性促进肝癌细胞增殖和侵袭。
Mol Cell Biochem. 2025 Mar 3. doi: 10.1007/s11010-025-05235-w.
10
m6A regulator-mediated methylation modification highlights immune infiltration patterns for predicting risk in hepatocellular carcinoma.m6A 调节子介导的甲基化修饰突出了免疫浸润模式，可用于预测肝细胞癌的风险。
J Cancer Res Clin Oncol. 2023 Jul;149(7):3661-3680. doi: 10.1007/s00432-022-04255-z. Epub 2022 Aug 16.

本文引用的文献

1
Strategies to enhance the response of liver cancer to pharmacological treatments.增强肝癌对药物治疗反应的策略。
Am J Physiol Cell Physiol. 2024 Jul 1;327(1):C11-C33. doi: 10.1152/ajpcell.00176.2024. Epub 2024 May 6.
2
Comprehensive Evaluation of The Infinium Human MethylationEPIC v2 BeadChip.Infinium人类甲基化EPIC v2芯片的综合评估
Epigenetics Commun. 2023;3(1). doi: 10.1186/s43682-023-00021-5. Epub 2023 Sep 27.
3
N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.
N6-甲基腺苷阅读器YTHDF1通过增强NOTCH1表达促进肝癌的干性和治疗抗性。
Cancer Res. 2024 Mar 15;84(6):827-840. doi: 10.1158/0008-5472.CAN-23-1916.
4
Plasma methylated GNB4 and Riplet as a novel dual-marker panel for the detection of hepatocellular carcinoma.血浆甲基化 GNB4 和 Riplet 作为一种新型双重标志物panel 用于检测肝细胞癌。
Epigenetics. 2024 Dec;19(1):2299044. doi: 10.1080/15592294.2023.2299044. Epub 2023 Dec 28.
5
Single-cell dissection of the multicellular ecosystem and molecular features underlying microvascular invasion in HCC.单细胞剖析多细胞生态系统和 HCC 微血管侵犯的分子特征。
Hepatology. 2024 Jun 1;79(6):1293-1309. doi: 10.1097/HEP.0000000000000673. Epub 2023 Nov 16.
6
N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.N6-甲基腺苷介导的 FZD10 上调通过 WNT/β-连环蛋白和 Hippo 信号通路调节肝癌干细胞特性和仑伐替尼耐药性。
Gastroenterology. 2023 May;164(6):990-1005. doi: 10.1053/j.gastro.2023.01.041. Epub 2023 Feb 8.
7
Global Epidemiology and Genetics of Hepatocellular Carcinoma.全球肝细胞癌的流行病学和遗传学
Gastroenterology. 2023 Apr;164(5):766-782. doi: 10.1053/j.gastro.2023.01.033. Epub 2023 Feb 2.
8
Genetic heterogeneity of liver cancer stem cells.肝癌干细胞的遗传异质性。
Anat Cell Biol. 2023 Mar 31;56(1):94-108. doi: 10.5115/acb.22.161. Epub 2022 Nov 17.
9
Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.肝细胞癌中癌相关成纤维细胞（CAF）的特征分析及基于单细胞 RNA-seq 和 bulk RNA-seq 数据构建 CAF 风险特征。
Front Immunol. 2022 Sep 23;13:1009789. doi: 10.3389/fimmu.2022.1009789. eCollection 2022.
10
Epigenetic remodelling in human hepatocellular carcinoma.人类肝细胞癌中的表观遗传重塑。
J Exp Clin Cancer Res. 2022 Mar 24;41(1):107. doi: 10.1186/s13046-022-02297-2.